The trial included 445 adults who were overweight or had obesity and knee osteoarthritis
Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications approved by the FDA for managing type 2 diabetes and, in some formulations, chronic weight management
He also discusses how the proper screenings, diet, supplements, and healthy lifestyle practices can prevent, and sometimes even treat, this pervasive heart issue in this informative Wellness Wisdom video segment
Glucose lowering at least 30% of the effect of a single 0.4 U/kg dose of LANTUS was not observed until the single dose of TOUJEO exceeded 0.6 U/kg
None of this is a prescription from us, it is context so you can evaluate claims for yourself
Sustainability 14(18):11536